Oligodendroglioma classification: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Oligodendroglioma may be classified according to the WHO classification of the central nervous system tumors into five subtypes: oligodendroglioma (OII), [[anaplastic|anaplastic oligodendroglioma (OIII)]], [[oligoastrocytoma|oligoastrocytoma (OAII)]], [[oligoastrocytoma|anaplastic oligoastrocytoma (OAIII)]], and [[glioblastoma|glioblastoma with oligodendroglioma component (GBMo)]]. | Oligodendroglioma may be classified according to the WHO classification of the central nervous system tumors into five subtypes: oligodendroglioma (OII), [[anaplastic|anaplastic oligodendroglioma (OIII)]], [[oligoastrocytoma|oligoastrocytoma (OAII)]], [[oligoastrocytoma|anaplastic oligoastrocytoma (OAIII)]], and [[glioblastoma|glioblastoma with oligodendroglioma component (GBMo)]]. | ||
==Classification== | ==Classification== | ||
Oligodendroglioma may be classified according to the WHO classification of the central nervous system tumors into five subtypes:<ref name="pmid17618441">{{cite journal| author=Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al.| title=The 2007 WHO classification of tumours of the central nervous system. | journal=Acta Neuropathol | year= 2007 | volume= 114 | issue= 2 | pages= 97-109 | pmid=17618441 | doi=10.1007/s00401-007-0243-4 | pmc=PMC1929165 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17618441 }} </ref> | * As of the 2016 update of the World Health Organization (WHO) classification of central nervous system tumors, oligodendroglial tumors are now more narrowly defined by molecular diagnostics to include only those diffuse gliomas harboring both a mutation in isocitrate dehydrogenase type 1 (''IDH1'') or type 2 (''IDH2'') '''and''' codeletion of chromosomes 1p and 19q. | ||
* Oligodendroglioma may be classified according to the WHO classification of the central nervous system tumors into five subtypes:<ref name="pmid17618441">{{cite journal| author=Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al.| title=The 2007 WHO classification of tumours of the central nervous system. | journal=Acta Neuropathol | year= 2007 | volume= 114 | issue= 2 | pages= 97-109 | pmid=17618441 | doi=10.1007/s00401-007-0243-4 | pmc=PMC1929165 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17618441 }} </ref> | |||
{{familytree/start |summary=WHO classification of tumors of CNS}} | {{familytree/start |summary=WHO classification of tumors of CNS}} | ||
{{familytree | | | | | | | | | | A01 | | | |A01=<div style="width: 10em; padding:1em;">'''WHO classification of tumors of CNS'''</div>}} | {{familytree | | | | | | | | | | A01 | | | |A01=<div style="width: 10em; padding:1em;">'''WHO classification of tumors of CNS'''</div>}} |
Revision as of 13:03, 1 May 2019
Oligodendroglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oligodendroglioma classification On the Web |
American Roentgen Ray Society Images of Oligodendroglioma classification |
Risk calculators and risk factors for Oligodendroglioma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]
Overview
Oligodendroglioma may be classified according to the WHO classification of the central nervous system tumors into five subtypes: oligodendroglioma (OII), anaplastic oligodendroglioma (OIII), oligoastrocytoma (OAII), anaplastic oligoastrocytoma (OAIII), and glioblastoma with oligodendroglioma component (GBMo).
Classification
- As of the 2016 update of the World Health Organization (WHO) classification of central nervous system tumors, oligodendroglial tumors are now more narrowly defined by molecular diagnostics to include only those diffuse gliomas harboring both a mutation in isocitrate dehydrogenase type 1 (IDH1) or type 2 (IDH2) and codeletion of chromosomes 1p and 19q.
- Oligodendroglioma may be classified according to the WHO classification of the central nervous system tumors into five subtypes:[1]
WHO classification of tumors of CNS | |||||||||||||||||||||||||||||||||||||||||||||
WHO grade II | WHO grade III | WHO grade IV | |||||||||||||||||||||||||||||||||||||||||||
Oligodendroglioma (OII) | |||||||||||||||||||||||||||||||||||||||||||||
Reference
- ↑ Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A; et al. (2007). "The 2007 WHO classification of tumours of the central nervous system". Acta Neuropathol. 114 (2): 97–109. doi:10.1007/s00401-007-0243-4. PMC 1929165. PMID 17618441.